Articles

Find an Article

Filter articles

Applied Filters

Showing 741 to 750 of 847 results

It’s good to litigate a patent or two

Germany01-01-2011

Europe is home to many life sciences companies, so IP regimes throughout the continent’s jurisdictions need to provide cost-effective, speedy and certain litigation environments if patent disputes are to be satisfactorily settled.

A revolution: biotech patents in India

India01-01-2011BiotechnologyArchana Shanker

It has taken a long time for India to develop a productive environment for biotechnology. But recent developments look to have put it on the right track. Archana Shanker explains.

Banning the patenting of biological materials in Australia: fact v fiction

Australia01-01-2011BiotechnologyTania Obranovich

An Australian legislative bill could have grave consequences for the country’s life sciences industry and, potentially, for patients as well. Tania Obranovich explains.

Patenting life

EPO, EU01-01-2011Biotech Directive, BiotechnologyAshley Roughton

A case before the Court of Justice for the European Union threatens to radically redraw the patent landscape for embryonic stem cells. Ashley Roughton explains.

Online issues at the ECJ

EU, Poland01-01-2011Anna Szajna and Maria Jurek

Since Poland’s accession to the EU, judgments of the Court of Justice of the European Union (ECJ) have been part of the Polish law and are applied directly with priority to national law. Anna Szajna and Maria Jurek take a look at the key cases.

AIPPI, Palais des Congrès, Paris

EPO01-12-2010

The 42nd AIPPI Intellectual Property Congress featured contributions from some of the most influential figures in IP and a lively debate among senior judges on the scope of patentability across jurisdictions.

CIPA, The Lancaster London Hotel, London

01-12-2010

Patent attorneys amassed at a London hotel to talk IP of the past decade and the next. WIPR looks at the highlights.

Judging dread: what is the EEUPC?

EU01-12-2010

IP is a booming business these days, and Europe’s myriad personalities are seen as a hindrance to cheap and effective patent protection. A European patent is obtainable, but enforcement is riddled with practical problems.

Consumers first: GlaxoSmithKline on trademarks

01-12-2010

People often think that IP in the healthcare sector is all about patents. But while GlaxoSmithKline certainly has a patent portfolio to protect, it also takes a strident approach to enforcing its trademarks and defending its brands.

Back to basics: renewing the foundations of innovation

US01-12-2010BiotechnologyJim Greenwood

The economic crisis has caused companies and governments alike to reassess their spending. Jim Greenwood explains why imperilling IP protection for the biotechnology industry would be the worst possible outcome.

Showing 741 to 750 of 847 results

Directory

Service Providers

Batavia Patentservis Asia (formerly Batavia Patent Agent)
Indonesia

TrademarkNow
Trademark Research Tools & Watching Services, Watching Services

Park IP Translations
Park IP is your trusted partner for legal language solutions

Practice Insight
Get the Information Edge with Practice Insight

WIPR